According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is A$0.83 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-09-30 | A$0.73 B | 311.85% |
2023-09-30 | A$0.17 B | 43.05% |
2022-09-30 | A$0.12 B | 252.05% |
2021-09-30 | A$35.57 M | 20.24% |
2020-09-30 | A$29.59 M | |
2019-09-30 | N/A | -100% |
2018-09-30 | A$3.21 M | -0.42% |
2017-09-30 | A$3.23 M | -9.61% |
2016-09-30 | A$3.57 M | 230.25% |
2015-09-30 | A$1.08 M | -7.68% |
2014-09-30 | A$1.17 M | -52.65% |
2013-09-30 | A$2.47 M | 5.5% |
2012-09-30 | A$2.34 M | 277.84% |
2011-09-30 | A$0.62 M | 20.47% |
2010-09-30 | A$0.51 M | -62.83% |
2009-09-30 | A$1.38 M | -28.43% |
2008-09-30 | A$1.93 M | |
2002-09-30 | A$1.16 M | 2.53% |
2001-09-30 | A$1.13 M | 9.89% |
2000-09-30 | A$1.03 M | 19.57% |
1999-09-30 | A$0.86 M | -52.06% |
1998-09-30 | A$1.8 M | 27.75% |
1997-09-30 | A$1.41 M |